Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?

J Natl Cancer Inst. 2010 Dec 15;102(24):1815-7. doi: 10.1093/jnci/djq466. Epub 2010 Nov 29.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenoma / prevention & control
  • Anticarcinogenic Agents / administration & dosage*
  • Anticarcinogenic Agents / adverse effects*
  • Breast Neoplasms / prevention & control
  • Carcinoma, Basal Cell / prevention & control
  • Carcinoma, Squamous Cell / prevention & control
  • Celecoxib
  • Chemoprevention / trends*
  • Colorectal Neoplasms / prevention & control
  • Cyclooxygenase 2 Inhibitors / administration & dosage
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Disease Progression
  • Female
  • Humans
  • Keratosis, Actinic / drug therapy
  • Keratosis, Actinic / pathology
  • Male
  • Neoplasms / prevention & control*
  • Preventive Medicine / trends*
  • Prostatic Neoplasms / prevention & control
  • Pyrazoles / administration & dosage
  • Pyrazoles / adverse effects
  • Randomized Controlled Trials as Topic
  • Risk Reduction Behavior*
  • Skin Neoplasms / prevention & control
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects
  • Terminology as Topic

Substances

  • Anticarcinogenic Agents
  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib